Graham was pleased to present an update on UK market access at the EUCOPE meeting on 12th June in Belgium.
Graham was pleased to present an update on UK market access at the EUCOPE meeting on 12th June in Belgium.
Joint Clinical Assessment (JCA) provides a common EU-level clinical assessment, but national HTA and...
Read moreManufacturers should not wait for final HTA scopes to test whether their evidence package can addres...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​
Get in touch